Thyroid Hormone Replacement for Central Hypothyroidism: A Randomized Controlled Trial Comparing Two Doses of Thyroxine (T4) with a Combination of T4 and Triiodothyronine
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Dosage of T(4) in central hypothyroidism is primarily guided by the free serum T(4) level (fT4). However, the optimum fT4 range is ill defined, and subtle hypothyroidism might be missed using this approach. OBJECTIVES: Our aim was to investigate the effects of a body weight (bw)-adapted T(4) treatment, alone or in combination with T(3), on metabolism, well-being, and cognitive function in comparison to a regimen leading to normal fT4. DESIGN: This was a placebo-controlled trial (double-blind, crossover). PATIENTS: A total of 29 patients (age 52 +/- 2 yr; females/males, 8/21) with hypopituitarism, including TSH deficiency, participated in the study. INTERVENTIONS: Three regimens were compared (5 wk each): "EMPIRICAL-T4," empirical T(4) dosage (1 +/- 0.05 microg/kg bw) leading to normal fT4; BW-ADAPTED-T4 (1.6 microg/kg bw T(4)); and "BW-ADAPTED-T3T4," bw-adapted combination of T(3) and T(4) (ratio of 1:10). RESULTS: BW-ADAPTED-T4 administration increased mean fT4 concentrations to the upper limit of the normal range (peak levels). Compared with EMPIRICAL-T4, BW-ADAPTED-T4 treatment resulted in a lower body mass index (BMI) (29.0 +/- 0.7 vs. 29.5 +/- 0.7 kg/m(2); P < 0.03), lower total cholesterol (198 +/- 9 vs. 226 +/- 7 mg/dl; P < 0.01), and lower low-density lipoprotein (LDL) cholesterol (116 +/- 5 vs. 135 +/- 7 mg/dl; P < 0.01). BW-ADAPTED-T3T4 treatment was associated with additional beneficial effects on ankle reflex time and working memory but resulted in supraphysiological free serum T(3) (fT(3)) levels. LIMITATIONS: Long-term side effects may have been missed. CONCLUSIONS: Using a dose of 1.6 microg/kg bw improved markers commonly associated with central hypothyroidism. This suggests that T(4) dosage based on bw and aiming at fT4 in the upper reference range is superior to titration of T(4) aiming at middle normal fT4 concentrations in those patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results of RCTs have indicated that cholesterol (50,82-86), and SHBG levels (50) are particularly affected by the administration of LT4.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [85]
In the citing paper
“However, in CeH where TSH is an unreliable monitor of thyroid hormone status, the risk of overtreatment by this approach is far higher than in primary hypothyroidism [49].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [49]
In the citing paper
“Since the only trial comparing standard levothyroxine (L-T4) and L-T4 + L-T3 combination therapy in CeH did not prove a superior efficacy of the combination [49]”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [49]
In the citing paper
“Several groups [49, 56, 58, 60] reported that concentrations of FT4 in the upper part of normal range might represent an appropriate target in most treated CeH patients (Recommendation 26).”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [49]
In the citing paper
“Some studies also report increased fT3 levels with no significant effects on TSH levels.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [81]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
A Standardized Memory Scale for Clinical Use
Wechsler, D. (1945) · The Journal of Psychology · doi:10.1080/00223980.1945.9917223 · Cited by 2,919
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482
Meier, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4860 · Cited by 401
Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Zulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 338
Research works printed but not linked: 3
- Jostel, 2006, Hypopituitarism, In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: Saunders;, 397
- Kessler, 1999, Demenz-Test, 2nd ed. Göttingen,, Germany, Hogrefe
- Zimmermann, 2000, Testbatterie zur Aufmerksamkeitsprüfung (TAP), Herzogenrath,, Germany, Psytest
Cited by
Items 101–121 of 121
Gärtner, R. (2010) · Elsevier eBooks · doi:10.1016/b978-3-437-24680-7.10021-2 · Cited by 1
Higham, C., & Trainer, P. J. (2013) · Medicine · doi:10.1016/j.mpmed.2013.06.011 · Cited by 1
Hypopituitarism, Causes, Diagnosis, Management and Mortality
Fountas, A., & Karavitaki, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64277-0 · Cited by 1
Bedecarratz, N. L. (2024) · UWA Profiles and Research Repository (UWA) · doi:10.26182/k555-qc54 · Cited by 1
Devin, J. K. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch29
Endocrine Issues Related to Stereotactic Radiosurgery in the Vicinity of the Pituitary Gland
Blevins, L. S. (2010) · Radiosurgery · doi:10.1159/000288735
3 Pathophysiology and Diagnosis of Central Hypothyroidism.
Yamada, M., & Mori, M. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.720
Patient Compliance and Awareness with Thyroid Replacement Therapy
Medicine, A. P. O. I., & Balla, A. A. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i12.126
Hormone Deficiency Syndromes of the Hypothalamic-Pituitary Axis
Polu, S., Sarmiento-Ramon, J. C., Haque, N., & Karam, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_11
Barker, J. M., & Triolo, T. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-52215-5_41
Ahmad, S. Z., Afzal, A., & Iqbal, A. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220169
Garla, V. V., Cardozo, L. L. Y., & Lien, L. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-99079-8_2
Luíz, H. V., Manita, I., & Portugal, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_7
Lania, A. G., Giavoli, C., Profka, E., & Beck-Peccoz, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_17
Higham, C., Shalet, S. M., & Trainer, P. J. (2009) · Medicine · doi:10.1016/j.mpmed.2009.05.004
Meiser, E. (2007) · FreiDok plus (Universitätsbibliothek Freiburg)
Self-citationОСОБЕННОСТИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ ВТОРИЧНОГО ГИПОТИРЕОЗА
Maslyanko, V. A. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Farklı D Vitamini Düzeylerinde Tiroid Hastalıkları Sıklığının Belirlenmesi
BAYRAK, İ. (2020) · AYBU AVESIS
Tsujimoto, Y., Yamashiro, K., Suzuki, Y., Watanabe, Y., & Nishimura, R. (2026) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2026.101720
Can Thyroid Dysfunction Contribute to Infertility via Lipid Abnormalities?
Kelly, R. B., Hassoun, A. A., Stępniak, J., Kaczmarek, P., & Karbownik‐Lewińska, M. (2026) · Cells · doi:10.3390/cells15201847
Metadata
- Authors
- Slawik, M., Klawitter, B., Meiser, E., Schories, M., Zwermann, O., Borm, K., Peper, M., Lubrich, B., Hug, M. J., Nauck, M., Olschewski, M., Beuschlein, F., & Reincke, M.
- Affiliations
- University Medical Center Freiburg (DE)
- Division of Endocrinology and Diabetes (M.Sl., B.K., E.M., M.Sc., K.B.), University Hospital Freiburg, 79104 Freiburg, Germany
- Ludwig-Maximilians-Universität München (DE)
- University of Bern (CH)
- Departments of Medizinische Klinik Innenstadt (M.Sl., O.Z., F.B., M.R.), University Hospital Innenstadt, Ludwig-Maximilians-University, D-80336 München, Germany
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11-01
- Volume
- 92
- Issue
- 11
- Pages
- 4115-4122
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096086720
- Cited by
- 113
- References
- 42
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 6 · 2013: 5 · 2012: 8
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- central hypothyroidism, hypopituitarism, TSH deficiency, thyroid hormone replacement, levothyroxine, triiodothyronine, free thyroxine, free triiodothyronine, cholesterol, LDL cholesterol, body mass index, working memory, ankle reflex, cognitive function, metabolism, dose comparison, placebo-controlled crossover trial
- MeSH terms
- Adolescent, Adult, Aged, Body Weight, Cognition, Double-Blind Method, Drug Combinations, Female, Humans, Hypothyroidism, Male, Middle Aged, Thyroid Hormones, Thyroxine, Triiodothyronine, Treatment Outcome, Muscle, Skeletal, Cross-Over Studies, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.